<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>赛柏蓝 | wechat-feeds</title><link>http://MjM5NTA4Mzc2Mg.favicon.privacyhide.com/favicon.ico</link><description>赛柏蓝（Mic366）,中国医药行业专业的资讯信息分享互动平台，致力于及时、准确、有用！</description><managingEditor> (hellodword)</managingEditor><pubDate>Sat, 27 Mar 2021 19:19:05 +0800</pubDate><image><url>http://MjM5NTA4Mzc2Mg.favicon.privacyhide.com/favicon.ico</url><title>赛柏蓝 | wechat-feeds</title><link>http://MjM5NTA4Mzc2Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>第五轮国采，时间传出</title><link>https://mp.weixin.qq.com/s/6OgVKKesRNh-KlqwqyP-9Q</link><description></description><content:encoded><![CDATA[第五轮国采，时间传出]]></content:encoded><pubDate>Sat, 27 Mar 2021 18:54:33 +0800</pubDate></item><item><title>第四批国采执行，最新通知来了</title><link>https://mp.weixin.qq.com/s/xDhs4vPp63KIghBIMt77Cg</link><description></description><content:encoded><![CDATA[第四批国采执行，最新通知来了]]></content:encoded><pubDate>Sat, 27 Mar 2021 18:54:33 +0800</pubDate></item><item><title>恒瑞：17个品种有望首仿</title><link>https://mp.weixin.qq.com/s/XS1ztAwpGGi3gIYLgfi1YA</link><description></description><content:encoded><![CDATA[恒瑞：17个品种有望首仿]]></content:encoded><pubDate>Sat, 27 Mar 2021 18:54:33 +0800</pubDate></item><item><title>中国医保研究报告，发布了</title><link>https://mp.weixin.qq.com/s/bfrT5MO8rNt_w4wq0aCMyQ</link><description></description><content:encoded><![CDATA[中国医保研究报告，发布了]]></content:encoded><pubDate>Sat, 27 Mar 2021 18:54:33 +0800</pubDate></item><item><title>一批药企火力全开做DTP：国控、上药...</title><link>https://mp.weixin.qq.com/s/OFrMpRdnkxq1RcoZmWHUSA</link><description></description><content:encoded><![CDATA[一批药企火力全开做DTP：国控、上药...]]></content:encoded><pubDate>Sat, 27 Mar 2021 18:54:33 +0800</pubDate></item><item><title>医药营销，也有一条龙服务</title><link>https://mp.weixin.qq.com/s/7E5lr90kAY42HxB5z2G6Vg</link><description></description><content:encoded><![CDATA[医药营销，也有一条龙服务]]></content:encoded><pubDate>Sat, 27 Mar 2021 18:54:33 +0800</pubDate></item><item><title>千亿糖尿病市场，有械企加码</title><link>https://mp.weixin.qq.com/s/O_QCUGz6irS5Kb5YIfCBjg</link><description></description><content:encoded><![CDATA[千亿糖尿病市场，有械企加码]]></content:encoded><pubDate>Sat, 27 Mar 2021 18:54:33 +0800</pubDate></item><item><title>一批高质量品种将上市：潜力大、竞品少...</title><link>https://mp.weixin.qq.com/s/KqkD9SgghglNm00bAPrm1g</link><description></description><content:encoded><![CDATA[一批高质量品种将上市：潜力大、竞品少...]]></content:encoded><pubDate>Sat, 27 Mar 2021 18:54:33 +0800</pubDate></item><item><title>一批医药代表将出局</title><link>https://mp.weixin.qq.com/s/7m1zM21sc0c4U7K_JkFfcg</link><description></description><content:encoded><![CDATA[一批医药代表将出局]]></content:encoded><pubDate>Fri, 26 Mar 2021 18:39:17 +0800</pubDate></item><item><title>两家知名大三甲，部分停诊</title><link>https://mp.weixin.qq.com/s/M5oEUJw0PuqbCs6pY0DE_w</link><description></description><content:encoded><![CDATA[两家知名大三甲，部分停诊]]></content:encoded><pubDate>Fri, 26 Mar 2021 18:39:17 +0800</pubDate></item><item><title>恒瑞PD-1，新适应症来了</title><link>https://mp.weixin.qq.com/s/94wlVacdYrKnzW2GpVANoA</link><description></description><content:encoded><![CDATA[恒瑞PD-1，新适应症来了]]></content:encoded><pubDate>Fri, 26 Mar 2021 18:39:17 +0800</pubDate></item><item><title>这三家药企真磨人</title><link>https://mp.weixin.qq.com/s/kGM0WSdMgk2uFYyWqPB4OQ</link><description></description><content:encoded><![CDATA[这三家药企真磨人]]></content:encoded><pubDate>Fri, 26 Mar 2021 18:39:17 +0800</pubDate></item><item><title>5月广州，医药电商及处方药网售开会了</title><link>https://mp.weixin.qq.com/s/puAvrgbu3hMm9Z9dGB7m0A</link><description></description><content:encoded><![CDATA[5月广州，医药电商及处方药网售开会了]]></content:encoded><pubDate>Fri, 26 Mar 2021 18:39:17 +0800</pubDate></item><item><title>《医药行业合规管理规范》发布，药企更谨慎了</title><link>https://mp.weixin.qq.com/s/gYMGtu2OcD_u9mW0VKuYQQ</link><description></description><content:encoded><![CDATA[《医药行业合规管理规范》发布，药企更谨慎了]]></content:encoded><pubDate>Fri, 26 Mar 2021 18:39:17 +0800</pubDate></item><item><title>集采常态化：企业创新转型政策来了！</title><link>https://mp.weixin.qq.com/s/vDDnl2ifv27GBXF_CP_ClQ</link><description></description><content:encoded><![CDATA[集采常态化：企业创新转型政策来了！]]></content:encoded><pubDate>Fri, 26 Mar 2021 18:39:17 +0800</pubDate></item><item><title>2021抓典型，药企合规太紧急</title><link>https://mp.weixin.qq.com/s/_cA1mCZsMVcV6MjKB6g2Fw</link><description></description><content:encoded><![CDATA[2021抓典型，药企合规太紧急]]></content:encoded><pubDate>Fri, 26 Mar 2021 18:39:17 +0800</pubDate></item><item><title>医药人最新工资数据发布</title><link>https://mp.weixin.qq.com/s/Bv1c73yvVn9zmLlyfUmI2w</link><description></description><content:encoded><![CDATA[医药人最新工资数据发布]]></content:encoded><pubDate>Thu, 25 Mar 2021 19:06:27 +0800</pubDate></item><item><title>三甲副院长落马，多名药企负责人涉案</title><link>https://mp.weixin.qq.com/s/Sn6ZQN94fXjHjMYszDh6Uw</link><description></description><content:encoded><![CDATA[三甲副院长落马，多名药企负责人涉案]]></content:encoded><pubDate>Thu, 25 Mar 2021 19:06:27 +0800</pubDate></item><item><title>带量采购，医药大省开始了</title><link>https://mp.weixin.qq.com/s/4CwuQoA1Ij9E8X5t_UsOlw</link><description></description><content:encoded><![CDATA[带量采购，医药大省开始了]]></content:encoded><pubDate>Thu, 25 Mar 2021 19:06:27 +0800</pubDate></item><item><title>重磅新药获批，300亿市场生变</title><link>https://mp.weixin.qq.com/s/0Fef1b-qa6htYYPNYWeL3w</link><description></description><content:encoded><![CDATA[重磅新药获批，300亿市场生变]]></content:encoded><pubDate>Thu, 25 Mar 2021 19:06:27 +0800</pubDate></item></channel></rss>